US6878687B1
(en)
|
1997-03-07 |
2005-04-12 |
Human Genome Sciences, Inc. |
Protein HMAAD57
|
CA2284131A1
(en)
|
1997-03-07 |
1998-09-11 |
Human Genome Sciences, Inc. |
70 human secreted proteins
|
CA2331386A1
(en)
|
1998-06-26 |
2000-01-06 |
Incyte Pharmaceuticals, Inc. |
Human signal peptide-containing proteins
|
AUPQ873300A0
(en)
|
2000-07-12 |
2000-08-03 |
Medvet Science Pty. Ltd. |
A binding motif of a receptor (2)
|
MXPA02010011A
(en)
|
2000-04-11 |
2003-04-25 |
Genentech Inc |
Multivalent antibodies and uses therefor.
|
JP2004522742A
(en)
|
2000-12-08 |
2004-07-29 |
ベイラー カレッジ オブ メディシン |
TREM-1 splice variants for use in modifying an immune response
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2342376C
(en)
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
EP1439857B1
(en)
|
2001-10-12 |
2009-02-25 |
Schering Corporation |
USE OF BISPECIFIC ANTIBODIES BINDING TO THE ACTIVATING RECEPTOR FcEpsilonRI AND TO THE INHIBITING RECEPTOR OX2Ra (CD200Ra) TO REGULATE IMMUNE RESPONSES
|
WO2003080667A2
(en)
|
2002-03-22 |
2003-10-02 |
Bioxell S.P.A. |
A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
WO2003099331A1
(en)
|
2002-05-24 |
2003-12-04 |
Takeda Pharmaceutical Company Limited |
Insulin resistance improving agents
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
US9714282B2
(en)
|
2003-09-26 |
2017-07-25 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
GB0401730D0
(en)
|
2004-01-27 |
2004-03-03 |
Bioxell Spa |
Diagnosis method
|
PL2314620T3
(en)
|
2004-05-27 |
2013-11-29 |
Crucell Holland Bv |
Method of identifying binding molecules capable of neutralizing rabies virus
|
US7700099B2
(en)
|
2005-02-14 |
2010-04-20 |
Merck & Co., Inc. |
Non-immunostimulatory antibody and compositions containing the same
|
US8101345B1
(en)
|
2005-03-25 |
2012-01-24 |
Isis Pharmaceuticals, Inc. |
Proinflammatory nucleic acids
|
KR20060135280A
(en)
|
2005-06-24 |
2006-12-29 |
전남대학교산학협력단 |
A cloning of trem-2 involving innate immunity
|
EP1959969A2
(en)
|
2005-07-01 |
2008-08-27 |
The Johns Hopkins University |
Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
DE202006007499U1
(en)
|
2006-05-11 |
2007-01-11 |
Osaka University |
Using composition that inhibits interaction between plexin-A1 and DAP-12 for treatment and prevention of inflammatory, autoimmune or bone resorption diseases
|
CA2654317A1
(en)
|
2006-06-12 |
2007-12-21 |
Trubion Pharmaceuticals, Inc. |
Single-chain multivalent binding proteins with effector function
|
CA2551163A1
(en)
|
2006-07-17 |
2008-01-17 |
Boehringer Ingelheim International Gmbh |
Methods for treating inflammatory, autoimmune or bone resorption diseases
|
US7553936B2
(en)
|
2006-12-04 |
2009-06-30 |
The United States of America as represented by Secretary Department of Health and Human Services |
Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
|
BRPI0806680A2
(en)
|
2007-01-16 |
2015-06-16 |
Wyeth Corp |
Treatment, detection and monitoring of train-1 inflammation
|
GR1007327B
(en)
|
2007-08-08 |
2011-06-27 |
Ευαγγελος Γιαμαρελλος-Μπουρμπουλης |
Soluble triggering receptor s-trem-1 used for activating the myeloid cells and controlling the efficiency of the peptic ulcer treatment
|
TW200918553A
(en)
*
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
KR100960684B1
(en)
|
2008-02-22 |
2010-05-31 |
전남대학교산학협력단 |
TREM-2 gene as an inhibitor of expression of GA733-2, and transgenic animals comprising the same and uses thereof
|
WO2010045479A1
(en)
|
2008-10-15 |
2010-04-22 |
The Board Of Trustees Of The University Of Illinois |
Phospholipid micellar and liposomal compositions and uses thereof
|
CA2759978C
(en)
|
2009-04-28 |
2020-06-02 |
Life & Brain Gmbh |
Method for obtaining human microglial precursor cells from pluripotent stem cells
|
WO2010132370A2
(en)
|
2009-05-11 |
2010-11-18 |
Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Soluble tlt-1 for the treatment and diagnosis of sepsis
|
CN102802661B
(en)
|
2009-06-22 |
2016-01-13 |
米迪缪尼有限公司 |
For the engineered Fc district of site-specific conjugation
|
US8513185B2
(en)
|
2009-10-13 |
2013-08-20 |
Alexander B. Sigalov |
Inhibition of TREM receptor signaling with peptide variants
|
CN102038698A
(en)
|
2009-10-14 |
2011-05-04 |
山东绿叶天然药物研究开发有限公司 |
New application of morroniside
|
JO3244B1
(en)
*
|
2009-10-26 |
2018-03-08 |
Amgen Inc |
Human il-23 antigen binding proteins
|
CN102127168A
(en)
|
2010-01-19 |
2011-07-20 |
中国人民解放军第二军医大学 |
Recombinant fusion protein of triggering receptor-1 expressed on myeloid cells (TREM-1) and application thereof
|
KR20110086460A
(en)
|
2010-01-22 |
2011-07-28 |
한국교원대학교산학협력단 |
Soluble receptor library and method for screening cytokine expression-regulating gene using the same
|
WO2011124685A1
(en)
|
2010-04-08 |
2011-10-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
|
WO2011137362A1
(en)
|
2010-04-30 |
2011-11-03 |
Rother Russell P |
Antibodies having reduced immunogenicity in a human
|
WO2012016333A1
(en)
|
2010-08-06 |
2012-02-09 |
University Health Network |
Biomarkers for malaria
|
US20130130354A1
(en)
|
2010-09-28 |
2013-05-23 |
CTI Salud S.A. |
Novel genes and uses thereof, expression profile of colon, gastric and pancreatic cancer
|
WO2012088302A2
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Half immunoglobulin binding proteins and uses thereof
|
US20120195900A1
(en)
|
2010-12-22 |
2012-08-02 |
Abbott Laboratories |
Tri-variable domain binding proteins and uses thereof
|
US10689447B2
(en)
|
2011-02-04 |
2020-06-23 |
Genentech, Inc. |
Fc variants and methods for their production
|
MX2013010172A
(en)
*
|
2011-03-11 |
2013-10-25 |
Amgen Inc |
Method of correlated mutational analysis to improve therapeutic antibodies.
|
KR20120112973A
(en)
|
2011-04-04 |
2012-10-12 |
전남대학교산학협력단 |
A composition for preventing or treating obesity or type 2 diabetes
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
EP3418306B1
(en)
|
2011-10-11 |
2023-12-06 |
F. Hoffmann-La Roche AG |
Improved assembly of bispecific antibodies
|
SG11201401658SA
(en)
|
2011-10-21 |
2014-07-30 |
Stemgenics Inc |
Functionalized nanoparticles for intracellular delivery of biologically active molecules
|
PT2773671T
(en)
|
2011-11-04 |
2021-12-14 |
Zymeworks Inc |
Stable heterodimeric antibody design with mutations in the fc domain
|
CA2854806A1
(en)
|
2011-11-07 |
2013-05-16 |
Medimmune, Llc |
Multispecific and multivalent binding proteins and uses thereof
|
EP3539982A3
(en)
|
2011-12-23 |
2020-01-15 |
Pfizer Inc |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
CN102517287B
(en)
|
2012-01-10 |
2013-09-11 |
广西大学 |
Short hairpin ribonucleic acid (shRNA) for inhibiting expression of buffalo triggering receptor expressed on myeloid cells 1 (TREM1) gene, lentiviral expression vector of shRNA and construction method and application of lentiviral expression vector
|
KR20130114951A
(en)
|
2012-04-10 |
2013-10-21 |
한양대학교 산학협력단 |
Composition for preventing or treating th17-mediated diseases comprising poly-gamma-glutamic acid
|
DK2892920T3
(en)
|
2012-09-07 |
2020-06-08 |
Inst Nat Sante Rech Med |
Inhibitory Peptides Derived from Trigger Receptor Expressed on Myeloid Cells-1 (TREM-1) TRIM-LIKE TRANSCRIPT 1 (TLT-1) AND APPLICATIONS THEREOF
|
CA3139031A1
(en)
|
2012-10-04 |
2014-04-10 |
Dana-Farber Cancer Institute, Inc. |
Human monoclonal anti-pd-l1 antibodies and methods of use
|
US9890216B2
(en)
|
2012-10-23 |
2018-02-13 |
Board Of Regents, The University Of Texas System |
Antibodies with engineered IgG Fc domains
|
WO2014074942A1
(en)
|
2012-11-08 |
2014-05-15 |
Illumina, Inc. |
Risk variants of alzheimer's disease
|
US9066928B1
(en)
*
|
2012-12-04 |
2015-06-30 |
University Of Kentucky Research Foundation |
Method, composition, and kit useful for treatment of alzheimer's disease
|
US9580486B2
(en)
|
2013-03-14 |
2017-02-28 |
Amgen Inc. |
Interleukin-2 muteins for the expansion of T-regulatory cells
|
KR20150010326A
(en)
|
2013-07-19 |
2015-01-28 |
전남대학교산학협력단 |
The biarylamide product derived compounds for preventing or treating obesity or type 2 diabetes or liver steatosis
|
CA2825821A1
(en)
|
2013-08-28 |
2015-02-28 |
Chiesi Farmaceutici S.P.A. |
1-phenylalkanecarboxylic acid derivatives for the treatment of alzheimer's disease and multiple sclerosis
|
KR101402921B1
(en)
|
2013-08-28 |
2014-06-02 |
전남대학교산학협력단 |
Use of resveratol derivatives for treating obesity or type 2 diabetes
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
CN103555829B
(en)
|
2013-10-12 |
2015-10-21 |
厦门人瑞生物医药科技有限公司 |
A kind of probe, test kit and method detecting TREM2 gene R47H and suddenly change
|
EP3092494A4
(en)
|
2014-01-06 |
2017-10-18 |
Children's Medical Center Corporation |
Biomarkers for dementia and dementia related neurological disorders
|
JOP20200096A1
(en)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
Antibody molecules to tim-3 and uses thereof
|
CN103866041A
(en)
|
2014-04-04 |
2014-06-18 |
厦门大学 |
Mutation detection kit for Parkinson disease and leukoaraiosis and detection method thereof
|
PT3129406T
(en)
|
2014-04-11 |
2019-04-24 |
Medimmune Llc |
Conjugated compounds comprising cysteine-engineered antibodies
|
CN105218669A
(en)
|
2014-06-10 |
2016-01-06 |
河北翰林生物科技有限公司 |
Prepare the method for the human monoclonal antibodies of anti-human R47H-TREM2 mutant
|
US20170218091A1
(en)
|
2014-07-03 |
2017-08-03 |
Abbvie Inc. |
Monovalent binding proteins
|
SG11201700250WA
(en)
|
2014-07-17 |
2017-02-27 |
Novo Nordisk As |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
|
IL279606B
(en)
*
|
2014-08-08 |
2022-08-01 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
KR101756417B1
(en)
|
2014-08-21 |
2017-07-10 |
한국유나이티드제약 주식회사 |
Pharmaceutical compositions comprising gold compound for preventing or treating fibrosis or cirrhosis of the liver
|
IL283834B
(en)
|
2014-09-28 |
2022-07-01 |
Univ California |
Modulation of stimulatory and non-stimulatory myeloid cells
|
WO2016064895A1
(en)
|
2014-10-20 |
2016-04-28 |
The Brigham And Women's Hospital, Inc. |
Targeting apolipoprotein e (apoe) in neurologic disease
|
US10081792B2
(en)
|
2014-12-31 |
2018-09-25 |
Wisconsin Alumni Research Foundation |
Derivation of human microglia from pluripotent stem cells
|
CA2982246A1
(en)
|
2015-04-17 |
2016-10-20 |
Alpine Immune Sciences, Inc. |
Immunomodulatory proteins with tunable affinities
|
JP2018516901A
(en)
|
2015-05-18 |
2018-06-28 |
シナプテック・ディヴェロップメント・エルエルシーSynaptec Development Llc |
Galantamine clearance of amyloid β
|
JP2018518491A
(en)
|
2015-06-12 |
2018-07-12 |
アレクトル エルエルシー |
Anti-CD33 antibody and method of use thereof
|
CA2988982A1
(en)
|
2015-06-12 |
2016-12-15 |
Alector Llc |
Anti-cd33 antibodies and methods of use thereof
|
CA2991209C
(en)
|
2015-07-04 |
2023-02-07 |
Emory University |
Use of trem-1 inhibitors for treatment, elimination and eradication of hiv-1 infection
|
WO2017011342A1
(en)
|
2015-07-10 |
2017-01-19 |
Abbvie Inc. |
Igm-or-ige-modified binding proteins and uses thereof
|
PE20231958A1
(en)
|
2015-07-30 |
2023-12-06 |
Macrogenics Inc |
BINDING MOLECULES TO PD-1 AND METHODS OF USE THEREOF
|
EP3341411A1
(en)
|
2015-08-28 |
2018-07-04 |
Alector LLC |
Anti-siglec-7 antibodies and methods of use thereof
|
WO2017058866A1
(en)
|
2015-09-28 |
2017-04-06 |
Precision Immune, Inc. |
Anti-trem2 antibodies and uses thereof
|
CA2997960A1
(en)
*
|
2015-10-06 |
2017-04-13 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
AU2016343987B2
(en)
|
2015-10-29 |
2023-11-23 |
Alector Llc |
Anti-Siglec-9 antibodies and methods of use thereof
|
US20170218058A1
(en)
|
2016-01-28 |
2017-08-03 |
Alector, LLC |
Anti-apoe4 antigen-binding proteins and methods of use thereof
|
EP3442543A4
(en)
|
2016-02-11 |
2020-01-22 |
The Johns Hopkins University |
Compositions and methods for neuralgenesis
|
WO2017147509A1
(en)
|
2016-02-25 |
2017-08-31 |
Marco Colonna |
Compositions comprising trem2 and methods of use thereof
|
JP7023853B2
(en)
|
2016-03-04 |
2022-02-22 |
アレクトル エルエルシー |
Anti-TREM1 antibody and its usage
|
US10875919B2
(en)
|
2016-04-26 |
2020-12-29 |
Alector Llc |
Chimeric receptors and methods of use thereof
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
WO2017210343A1
(en)
|
2016-06-01 |
2017-12-07 |
The University Of Virginia Patent Foundation |
Methods and compositions for modulating lymphatic vessels in the central nervous system
|
JP2019531332A
(en)
|
2016-07-22 |
2019-10-31 |
ドイチェス ツェントルム フュール ノイロデゲネラティフェ アークランクンゲン エー.ファウ.(デーツェットエンエー) |
TREM2 cleavage modulator and use thereof
|
CN106244682B
(en)
|
2016-07-29 |
2019-11-26 |
中山大学 |
TREM-2 gene is identifying pig to the application in blue ear virus susceptibility
|
CN106636330B
(en)
|
2016-09-21 |
2017-12-15 |
郁金泰 |
The diagnosis of Alzheimer disease and medicine
|
CA3040687A1
(en)
|
2016-10-14 |
2018-04-19 |
Childrens' Medical Center Corporation |
Compositions and methods for treating diseases and disorders of the central nervous system
|
CA3044684A1
(en)
|
2016-12-09 |
2018-06-14 |
Alector Llc |
Anti-sirp-alpha antibodies and methods of use thereof
|
EP3558340A4
(en)
|
2016-12-23 |
2020-07-22 |
Genervon Biopharmaceuticals LLC |
Methods of using gm6 in diagnosing and treating alzheimer's disease
|
CN110573167A
(en)
|
2017-01-12 |
2019-12-13 |
杜克大学 |
Compositions and methods for treating demyelinating diseases
|
WO2018134815A2
(en)
|
2017-01-17 |
2018-07-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating neurodegenerative diseases by inducing disease-associated microglia (dam) cells
|
US20190365830A1
(en)
|
2017-01-18 |
2019-12-05 |
Evelo Biosciences, Inc. |
Methods of treating cancer
|
US20190336615A1
(en)
|
2017-01-27 |
2019-11-07 |
Silverback Therapeutics, Inc. |
Tumor targeting conjugates and methods of use thereof
|
US10143187B2
(en)
|
2017-02-17 |
2018-12-04 |
Denali Therapeutics Inc. |
Transferrin receptor transgenic models
|
US20210293794A1
(en)
|
2017-02-24 |
2021-09-23 |
University Of Hawii Cancer Center |
Metabolic biomarkers for the identification and characterization of alzheimers disease
|
WO2018160496A1
(en)
|
2017-02-28 |
2018-09-07 |
The Regents Of The University Of California |
Differentiation and use of human microglia-like cells from pluripotent stem cells and hematopoietic progenitors
|
CA3057289A1
(en)
|
2017-03-21 |
2018-09-27 |
The Jackson Laboratory |
A genetically modified mouse expressing human apoe4 and mouse trem2 p.r47h and methods of use thereof
|
KR101936249B1
(en)
|
2017-04-04 |
2019-01-08 |
경희대학교 산학협력단 |
Composition for preventing, improving or treating cancer comprising kumatakenin
|
JOP20190248A1
(en)
|
2017-04-21 |
2019-10-20 |
Amgen Inc |
Trem2 antigen binding proteins and uses thereof
|
US20180318379A1
(en)
|
2017-05-01 |
2018-11-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibition of triggering receptor expressed on myeloid cells 1 (trem1) to treat central nervous system disorders
|
WO2018213316A1
(en)
|
2017-05-16 |
2018-11-22 |
Alector Llc |
Anti-siglec-5 antibodies and methods of use thereof
|
WO2018218090A1
(en)
|
2017-05-24 |
2018-11-29 |
Nanosomix, Inc. |
Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders
|
JP2020522266A
(en)
|
2017-06-05 |
2020-07-30 |
ヤンセン バイオテツク,インコーポレーテツド |
Engineered multispecific antibodies and other multimeric proteins with asymmetric mutations in the CH2-CH3 region
|
JP7356970B2
(en)
|
2017-06-25 |
2023-10-05 |
システィミューン, インク. |
Multispecific antibodies and their production and use methods
|
CN109206503A
(en)
|
2017-07-07 |
2019-01-15 |
厦门大学 |
A kind of albumen is used to prepare the purposes of prevention and treatment Alzheimer disease drugs
|
US20190008812A1
(en)
|
2017-07-07 |
2019-01-10 |
Washington University |
Methods for treating microglial dysfunction
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
Anti-nucleolin antibody
|
AU2018307877A1
(en)
|
2017-07-27 |
2020-01-02 |
Novartis Ag |
Sheddase resistant TREM2 variants
|
WO2019028292A1
(en)
|
2017-08-03 |
2019-02-07 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
CN110662765B
(en)
|
2017-08-03 |
2023-09-29 |
艾利妥 |
anti-CD 33 antibodies and methods of use thereof
|
WO2019032624A1
(en)
|
2017-08-08 |
2019-02-14 |
Pionyr Immunotherapeutics, Inc. |
Compositions and methods for disabling meyloid cells expressing trem1
|
JP7403441B2
(en)
|
2017-09-14 |
2023-12-22 |
デナリ セラピューティクス インコーポレイテッド |
Anti-TREM2 antibody and method of use thereof
|
US20200309788A1
(en)
|
2017-09-29 |
2020-10-01 |
The General Hospital Corporation |
Methods for identifying and treating adrenomyeloneuropathy (amn)
|
US11364303B2
(en)
|
2017-09-29 |
2022-06-21 |
Pfizer Inc. |
Cysteine engineered antibody drug conjugates
|
EP3692158A4
(en)
|
2017-10-03 |
2021-08-04 |
Prevail Therapeutics, Inc. |
Gene therapies for lysosomal disorders
|
WO2019079529A1
(en)
|
2017-10-17 |
2019-04-25 |
The Translational Genomics Research Institute |
Trem2 agonists for the stimulation of microglia and methods of identification
|
US10597462B1
(en)
|
2017-11-08 |
2020-03-24 |
University Of Puerto Rico |
Anti-TLT-1 antibody and uses thereof
|
JP2021502977A
(en)
|
2017-11-15 |
2021-02-04 |
ユニバルシテ ラバル |
Use of SRSF3 agonists for the treatment and / or prevention of neurological conditions, cancer, bacterial or viral infections
|
CN109837330A
(en)
|
2017-11-28 |
2019-06-04 |
上海中优精准医疗科技股份有限公司 |
A kind of probe and method detecting TREM2 gene pleiomorphism
|
BR112020011833A2
(en)
|
2017-12-12 |
2020-11-24 |
Pionyr Immunotherapeutics, Inc. |
anti-trem2 antibodies and related methods
|
US11470827B2
(en)
|
2017-12-12 |
2022-10-18 |
Alector Llc |
Transgenic mice expressing human TREM proteins and methods of use thereof
|
US11472874B2
(en)
|
2018-01-31 |
2022-10-18 |
Alector Llc |
Anti-MS4A4A antibodies and methods of use thereof
|
CN111971397A
(en)
|
2018-02-14 |
2020-11-20 |
耶鲁大学 |
Compositions for modulating TREM or TREML proteins and methods of use thereof
|
NL2020520B1
(en)
|
2018-03-02 |
2019-09-12 |
Labo Bio Medical Invest B V |
Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
|
US20210000807A1
(en)
|
2018-03-22 |
2021-01-07 |
Nsc Therapeutics Gmbh |
Compounds and methods for use in the treatment of microglia-mediated disorders
|
KR20200139219A
(en)
|
2018-04-02 |
2020-12-11 |
브리스톨-마이어스 스큅 컴퍼니 |
Anti-TREM-1 antibodies and uses thereof
|
US20210059977A1
(en)
|
2018-04-09 |
2021-03-04 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotrophic lateral sclerosis and related disorders
|
CN112218893A
(en)
|
2018-05-25 |
2021-01-12 |
艾利妥 |
anti-SIRPA antibodies and methods of use thereof
|
WO2019236965A1
(en)
|
2018-06-08 |
2019-12-12 |
Alector Llc |
Anti-siglec-7 antibodies and methods of use thereof
|
CN108752482B
(en)
|
2018-06-12 |
2019-04-30 |
南京卡提医学科技有限公司 |
Carry the Chimeric antigen receptor and its application of truncation or not truncated myeloid cell triggering property receptor signal structure
|
WO2019246483A1
(en)
|
2018-06-21 |
2019-12-26 |
The Jackson Laboratory |
Genetically modified mouse models of alzheimer's disease
|
AU2019293589A1
(en)
|
2018-06-29 |
2021-01-21 |
Alector Llc |
Anti-SIRP-beta1 antibodies and methods of use thereof
|
EP3820520A4
(en)
|
2018-07-12 |
2022-05-11 |
Corvus Pharmaceuticals, Inc. |
Methods for detecting and treating cancers having adenosine pathway activation
|
US11278575B2
(en)
|
2018-07-12 |
2022-03-22 |
Duke University |
Compositions and methods for the treatment of demyelinating conditions
|
US20210311076A1
(en)
|
2018-07-16 |
2021-10-07 |
University Of Virginia Patent Foundation |
Compositions and methods of diagnosis and treatment for neurological diseases
|
CN109112214A
(en)
|
2018-07-27 |
2019-01-01 |
复旦大学附属中山医院 |
Application of the pattern recognition receptors TREM2 in prognosis in hcc and treatment
|
EA202190183A1
(en)
|
2018-07-27 |
2021-05-18 |
Алектор Ллс |
ANTIBODIES TO SIGLEC-5 AND METHODS OF THEIR APPLICATION
|
EA202190235A1
(en)
|
2018-08-31 |
2021-07-02 |
Алектор Ллс |
ANTIBODIES TO CD33 AND METHODS OF THEIR APPLICATION
|
WO2020051322A1
(en)
|
2018-09-05 |
2020-03-12 |
The General Hospital Corporation |
Methods of treating cytokine release syndrome
|
JP2022500081A
(en)
|
2018-09-11 |
2022-01-04 |
ワシントン・ユニバーシティWashington University |
Anti-TREM-2 agonist antibody
|
WO2020056114A1
(en)
|
2018-09-12 |
2020-03-19 |
Board Of Regents Of The University Of Nebraska |
Antimicrobial compositions and methods
|
JP2022513324A
(en)
|
2018-09-28 |
2022-02-07 |
イノトレム |
Use of soluble TREM-1 levels to identify subjects who are more responsive to anti-inflammatory therapy
|
UY38407A
(en)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
TREM2 STABILIZING ANTIBODIES
|
KR102096282B1
(en)
|
2018-10-15 |
2020-04-02 |
재단법인대구경북과학기술원 |
Method for effective purification of human TREM2 proteins using recombinant baculovirus
|
KR102156165B1
(en)
|
2018-10-29 |
2020-09-15 |
재단법인대구경북과학기술원 |
Monoclonal antibody with specificity for human TREM2 protein, hybridoma cell line producing the same and use thereof
|
CN111135185A
(en)
|
2018-11-02 |
2020-05-12 |
杭州星鳌生物科技有限公司 |
Natural immune activation through regulating medullary cell triggering receptor TREM2 to inhibit chronic inflammation of cerebral nerve
|
US20220127373A1
(en)
|
2018-11-08 |
2022-04-28 |
The Regents Of The University Of California |
Systems and methods for targeting cancer cells
|
CN113302206A
(en)
|
2018-11-26 |
2021-08-24 |
戴纳立制药公司 |
Methods of treating lipid metabolism disorders
|
WO2020121195A1
(en)
|
2018-12-10 |
2020-06-18 |
Mor Research Applications |
Trem2 antibodies and uses thereof
|
AR117453A1
(en)
|
2018-12-20 |
2021-08-04 |
Genentech Inc |
CF OF MODIFIED ANTIBODIES AND METHODS TO USE THEM
|
WO2020142659A2
(en)
|
2019-01-04 |
2020-07-09 |
Trio Pharmaceuticals, Inc. |
Multi-specific protein molecules and uses thereof
|
CN109646668B
(en)
|
2019-01-04 |
2019-10-18 |
厦门大学 |
A kind of polypeptide is used to prepare the purposes of prevention and treatment Alzheimer disease drugs
|
US20220119532A1
(en)
|
2019-01-14 |
2022-04-21 |
University Of Virginia Patent Foundation |
Use of integrin inhibitors for treatment or prevention of a neurological immunity disorder and/or nervous system injury
|
US20220104468A1
(en)
|
2019-01-22 |
2022-04-07 |
St. Jude Children's Research Hospital |
Modulation of lc3-associated endocytosis pathway and genetically modified non-human animals as a model of neuroinflammation and neurodegeneration
|
US20220099659A1
(en)
|
2019-01-23 |
2022-03-31 |
The Regents Of The University Of California |
Human Genomic Construct Reporter Cells and Mouse Models to Screen Therapeutics against Microglia-expressed Disease Associated Genes
|
US20220133808A1
(en)
|
2019-02-01 |
2022-05-05 |
Avrobio, Inc. |
Compositions and methods for treating neurocognitive disorders
|
EP3917623A4
(en)
|
2019-02-01 |
2022-10-19 |
Avrobio, Inc. |
Compositions and methods for treating neurocognitive disorders
|
AU2020214807A1
(en)
|
2019-02-01 |
2021-08-05 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Microenvironment sensors to regulate engineered gene expression
|
SG11202108734VA
(en)
|
2019-02-20 |
2021-09-29 |
Denali Therapeutics Inc |
Anti-trem2 antibodies and methods of use thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
CN110320368A
(en)
|
2019-05-30 |
2019-10-11 |
广州医科大学附属第一医院(广州呼吸中心) |
Diagnostic kit based on TREM2 and its application on diagnosis of Parkinson disease product
|
CN110241208A
(en)
|
2019-08-02 |
2019-09-17 |
辽宁中医药大学 |
Application of the TREM2 as the molecular marker of early diagnosis coronary heart disease
|
CN110511240B
(en)
|
2019-08-27 |
2022-03-08 |
南京医科大学 |
Endogenous ligand of myeloid cell trigger receptor 2 and application thereof
|
CN110882262A
(en)
|
2019-11-06 |
2020-03-17 |
南京医科大学 |
Medicine for activating marrow cell trigger receptor 2 and application thereof
|
BR112022007944A2
(en)
|
2019-11-22 |
2022-07-12 |
Lilly Co Eli |
TREM2 ANTIBODIES AND USES THEREOF
|
KR20220110537A
(en)
|
2019-12-05 |
2022-08-08 |
알렉터 엘엘씨 |
How to Use Anti-TREM2 Antibodies
|
CN111184742B
(en)
|
2020-02-13 |
2022-06-24 |
中山大学附属第五医院 |
Application of TREM-2+ T cells in preparation of drugs for treating tuberculosis
|